Mechanisms of adverse effects of β-agonists in asthma

Thorax

Volumn 64, Issue 9, 2009, Pages 739-741

  Johnston, Sebastian L ^a   Edwards, Michael R ^a  

^a NATIONAL HEART AND LUNG INSTITUTE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ADRENERGIC RECEPTOR STIMULATING AGENT; BRAIN DERIVED NEUROTROPHIC FACTOR; CYCLIC AMP; CYCLOOXYGENASE 2; FLUTICASONE; GELATINASE A; INTERLEUKIN 17; INTERLEUKIN 6; LONG ACTING DRUG; MUCIN 5AC; MUCIN 8; SALBUTAMOL; SALMETEROL; SHORT ACTING DRUG;

AIRWAY OBSTRUCTION; ANTIINFLAMMATORY ACTIVITY; ASTHMA; BRONCHODILATING ACTIVITY; BRONCHUS HYPERREACTIVITY; CORTICOSTEROID THERAPY; CYCLIC AMP RESPONSIVE ELEMENT; DEATH; DISEASE EXACERBATION; DISEASE SEVERITY; DRUG INFORMATION; DRUG MECHANISM; DRUG SAFETY; EDITORIAL; EOSINOPHIL COUNT; EOSINOPHILIA; FOOD AND DRUG ADMINISTRATION; HUMAN; IN VITRO STUDY; IN VIVO STUDY; LUNG FUNCTION; LUNG PARENCHYMA; MONOTHERAPY; PRIORITY JOURNAL; RHINOVIRUS; RHINOVIRUS INFECTION; SMOOTH MUSCLE RELAXATION; TH17 CELL; THROMBOCYTE COUNT;

EID: 69749104949     PISSN: 00406376     EISSN: 14683296     Source Type: Journal    
DOI: 10.1136/thx.2009.119230     Document Type: Editorial

References (26)

1. Anderson HR, Ayres JG, Sturdy PM, et al. Bronchodilator treatment and deaths from asthma: case-control study. BMJ 2005;330:117.
2. Hasford J, Virchow JC. Excess mortality in patients with asthma on long-acting beta2-agonists. Eur Respir J 2006;28:900-902 (Pubitemid 46331955)
3. Crane J, Pearce N, Flatt A, et al. Prescribed fenoterol and death from asthma in New Zealand, 1981-1983: case-control study. Lancet 1989;1:917-922
4. Beasley R, Nishima S, Pearce N, et al. Beta-agonist therapy and asthma mortality in Japan. Lancet 1998;351:1406-1407 (Pubitemid 28210006)
5. Sears MR. Adverse effects of beta-agonists. J Allergy Clin Immunol 2002;110(6 Suppl):S322-8.
6. McIvor RA, Pizzichini E, Turner MO, et al. Potential masking effects of salmeterol on airway inflammation in asthma. Am J Respir Crit Care Med 1998;158:924-930 (Pubitemid 28449462)
7. Nelson HS, Weiss ST, Bleecker ER, et al. The Salmeterol Multicenter Asthma Research Trial: a comparison of usual pharmacotherapy for asthma or usual pharmacotherapy plus salmeterol. Chest 2006;129:15-26.
8. Drazen JM, Israel E, Boushey HA, et al. Comparison of regularly scheduled with as-needed use of albuterol in mild asthma. Asthma Clinical Research Network. N Engl J Med 1996;335:841-847
9. Aldridge RE, Hancox RJ, Cowant JO, et al. Eosinophils and eosinophilic cationic protein in induced sputum and blood: effects of budesonide and terbutaline treatment. Ann Allergy Asthma Immunol 2002;89:492-497
10. Lommatzsch M, Lindner Y, Edner A, et al. Adverse effects of salmeterol in asthma: a neuronal perspective. Thorax 2009;64:763-769
11. Nassenstein C, Braun A, Erpenbeck VJ, et al. The neurotrophins nerve growth factor, brain-derived neurotrophic factor, neurotrophin-3, and neurotrophin- 4 are survival and activation factors for eosinophils in patients with allergic bronchial asthma. J Exp Med 2003;198:455-467 (Pubitemid 36976056)
12. Edwards MR, Haas J, Panettieri RA Jr, et al. Corticosteroids and beta2 agonists differentially regulate rhinovirus-induced interleukin-6 via distinct cis-acting elements. J Biol Chem 2007;282:15366-15375 (Pubitemid 47093295)
13. Tabuchi A, Sakaya H, Kisukeda T, et al. Involvement of an upstream stimulatory factor as well as cAMP-responsive element-binding protein in the activation of brain-derived neurotrophic factor gene promoter I. J Biol Chem 2002;277:35920-35931
14. Boniface K, Bak-Jensen KS, Li Y, et al. Prostaglandin E2 regulates Th17 cell differentiation and function through cyclic AMP and EP2/EP4 receptor signaling. J Exp Med 2009;206:535-548
15. Kleinschek MA, Boniface K, Sadekova S, et al. Circulating and gut-resident human Th17 cells express CD161 and promote intestinal inflammation. J Exp Med 2009;206:525-534
16. Wu W, Silbajoris RA, Cao D, et al. Regulation of cyclooxygenase-2 expression by cAMP response element and mRNA stability in a human airway epithelial cell line exposed to zinc. Toxicol Appl Pharmacol 2008;231:260-266
17. Melnikova VO, Mourad-Zeidan AA, Lev DC, et al. Platelet-activating factor mediates MMP-2 expression and activation via phosphorylation of cAMP-response element-binding protein and contributes to melanoma metastasis. J Biol Chem 2006;281:2911-2922
18. Song KS, Seong JK, Chung KC, et al. Induction of MUC8 gene expression by interleukin-1 beta is mediated by a sequential ERK MAPK/RSK1/CREB cascade pathway in human airway epithelial cells. J Biol Chem 2003;278:34890-34896
19. Song KS, Lee TJ, Kim K, et al. cAMP-responding element-binding protein and c-Ets1 interact in the regulation of ATP-dependent MUC5AC gene expression. J Biol Chem 2008;283:26869-26878
20. Zhang X, Odom DT, Koo SH, et al. Genome-wide analysis of cAMP-response element binding protein occupancy, phosphorylation, and target gene activation in human tissues. Proc Natl Acad Sci USA 2005;102:4459-4464 (Pubitemid 40397134)
21. Chen Y, Nickola TJ, DiFronzo NL, et al. Dexamethasone-mediated repression of MUC5AC gene expression in human lung epithelial cells. Am J Respir Cell Mol Biol 2006;34:338-347 (Pubitemid 43320715)
22. Ishinaga H, Takeuchi K, Kishioka C, et al. Effects of dexamethasone on mucin gene expression in cultured human nasal epithelial cells. Laryngoscope 2002;112:1436-1440 (Pubitemid 34875429)
23. Molet SM, Hamid QA, Hamilos DL. IL-11 and IL-17 expression in nasal polyps: relationship to collagen deposition and suppression by intranasal fluticasone propionate. Laryngoscope 2003;113:1803-1812
24. Edwards MR, Johnson MW, Johnston SL. Combination therapy: synergistic suppression of virus induced chemokines in airway epithelial cells. Am J Respir Cell Mol Biol 2006;34:616-624
25. Kaur M, Holden NS, Wilson SM, et al. Effect of beta2-adrenoceptor agonists and other cAMPelevating agents on inflammatory gene expression in human ASM cells: a role for protein kinase A. Am J Physiol Lung Cell Mol Physiol 2008;295:L505-14.
26. Harrison B, Stephenson P, Mohan G, et al. An ongoing Confidential Enquiry into asthma deaths in the Eastern Region of the UK, 2001-2003. Prim Care Respir J 2005;14:303-313